Latest Conference Articles

In a world where she practices dermatology, conducts research, and is a super mom, Alina Bridges, DO has nailed down a strategy to not let emails stress her out.

The treatment was deemed effective following a phase 3 study.

Ronda Farah, MD, FAAD, shares her tips and tricks for treating varying types of alopecia.

A review on breast cancer screenings and procedures on the chest is essential to ensure proper gender-affirming care.

Patients with common psychocutaneous diseases, including body dysmorphic disorder (BDD), often refuse a psychiatric referral and instead, present to dermatologists and cosmetic surgeons.

Joshua Zeichner, MD, delivered a boot camp on isotretinoin use at AAD 2023, including an overview of newer formulations of the acne drug that could help counter the common absorption challenges.

What can you do when a medication for psoriasis yields a suboptimal response? New data presented at the 2023 AAD Annual Meeting provides valuable insight on next steps for treatment.

With the recent therapeutic revolution, there has never been a better time to find the right treatment option for your patient suffering from inflammatory diseases.

The impacts of discrimination, harassment, and microaggressions have lasting impact on a clinician’s performance, mental health, and career. Here’s how to create a respectful culture.

An AAD 2023 poster presentation reviewed the long-term safety periods of the TruE-AD1 and TRuE-AD2 trials.

“The present and future is narrow-spectrum antibiotics because they enhance antibiotic stewardship, they protect the host microbiome, [and] they reduce antibiotic resistance,” AAD 2023 presenter Christopher Bunick, MD, PhD, said.

A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA.

Promising phase 2 data for LY3041658 released during the Late-breaking Research session at the 2023 annual meeting.

In a shared session at AAD, Ramona Behshad, MD, FAAD, will present a hands-on surgical scar revision workshop using cadavers.

Atopic Dermatitis treatment and management options are explored at several sessions conducted by Peter Lio, MD, FAAD, at AAD 2023.

The latest phase 3 trial results were showcased in an AAD late-breaking research session.

Patients with squamous cell carcinoma who experience immunosuppression are at a greater risk.

Wu delves into her AAD involvement as she presents in sessions centered around the importance of patch testing and how clinical guidelines are created.

Expert warns lack of proper diagnosis and complete and thorough treatment of onychomycosis can lead to an endemic issue.

Designed to address the underlying causes of DEB, the investigational topical gene therapy shows great promise to improve quality of life for patients with this rare disorder.

Bhatia shares key pearls from his sessions at AAD 2023 discussing office politics and how to run a clinical research unit.

Victoria Barbosa, MD, FAAD, shares pearls on the clinical recognition and management of alopecia in Black women.

She and her colleagues illustrated the role of direct immunofluorescence plays in the evaluation of autoimmune blistering disorders.

Transgender and cisgender patients presenting with acne face differences in acne treatment and prescribing patterns.

According to his AAD 2023 session, Matarasso stresses it’s crucial to consider the type of patient you want as a loyal patient.

Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.

This AAD panel will feature a lively discussion on how to handle difficult or complex medical dermatology cases, with illustrative case studies on dermatomyositis, hidradenitis suppurativa, atopic dermatitis, and more.

The Skin of Color Society challenged dermatologists, residents, and medical students to address racial disparities in dermatologic care and shared best practices to serve patients of color.